FDA inspection
Lianyungang Runzhong Pharmaceutical Co., Ltd.: FDA inspection ending Jan 26, 2024
FDA inspection 1230851 · No Action Indicated (NAI) · Lianyungang
Key facts
| Inspection ID | 1230851 |
|---|---|
| Firm | Lianyungang Runzhong Pharmaceutical Co., Ltd. |
| FEI number | 3003015655 |
| Address | Jinqiao Rd., Dapu Industrial Park No. 16, Economic; Technology Development Zone |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jan 26, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data